SHERLOCK Biosciences in the News.
News Overview
Read about Sherlock’s work to revolutionize molecular diagnostics and bring highly accurate, rapid, and affordable testing to the world.
October 31, 2019
- GENOME WEB
Sherlock Biosciences Aims to Create Dx Tool for ‘Where Testing Should be Done, But Isn’t‘October 31, 2019
- Genetic Engineering & Biotechnology News
Forces Unite to Move Molecular Dx Out of the GatesOctober 29, 2019
Sherlock Biosciences and Mologic Establish Strategic Partnership to Develop Instrument-free Molecular Diagnostic TestsSeptember 26, 2019
- BOSTON BUSINESS JOURNAL
Sherlock Bio gets DoD grant to bring CRISPR to the battlefieldSeptember 26, 2019
Sherlock Biosciences Awarded Contract from U.S. Defense Threat Reduction Agency to Support the Development of Ultra-Fast, Ultra-Sensitive DiagnosticsSeptember 24, 2019
- BostInno
Sherlock Named one of BostInno’s 2019 50 on Fire Recipients in Health CareApril 23, 2019
Sherlock Biosciences Announces Close of Series A Round with Additional Investment Led by Northpond Ventures and Baidu VenturesMarch 21, 2019
Sherlock Biosciences Launches to Provide Better, Faster and More Affordable Diagnostic Testing Worldwide Through Engineering BiologyApril 13, 2017
- STAT News
CRISPR cousin SHERLOCK may be able to track down diseases, scientists sayApril 13, 2017
- Washington Post
A new CRISPR breakthrough could lead to simpler, cheaper disease diagnosisApril 27, 2018
- Science
Multiplexed and portable nucleic acid detection platform with Cas13, Cas12a, and Csm6August 05, 2016
- Science
C2c2 is a single-component programmable RNA-guided RNA-targeting CRISPR effector